Publications by authors named "Scott T Guenthner"

Claim this Profile
R
Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial.
Andrew Blauvelt, Zoe D Draelos, Linda Stein Gold, Javier Alonso-Llamazares, Neal Bhatia, Scott T Guenthner

J Am Acad Dermatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.
Matthew J Zirwas, Zoe D Draelos, Janet DuBois, Leon H Kircik, Angela Y Moore, Scott T Guenthner

JAMA Dermatol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Halobetasol Propionate Lotion 0.01% for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis in Male and Female Participants.
Fran E Cook-Bolden, Adelaide A Hebert, Scott T Guenthner, Robert Kang, Gina Martin

J Drugs Dermatol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A skin cancer education initiative at a professional baseball game and results of a skin cancer survey.
Emily Ann Jungers, Scott Thomas Guenthner, Evan R Farmer, Susan M Perkins

Int J Dermatol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis